← Latest Viking Global portfolio

Viking Global portfolio · 2023-03-31

Form 13F reports holdings as of 2023-03-31 and was filed on 2023-05-15. It is delayed, can omit confidential positions, and is not the manager's current portfolio or fund NAV. Options show reported underlying value—not premium, net exposure, or investment intent.

Disclosed long book

$21.23 billion

Long positions

81

Calls / puts

0 / 0

Top 5 concentration

25.6%

Longs with AI data

11 / 81

Average AI 1Y

+19.8%

13F filing comparison

Quarter-over-quarter changes

2022-12-31 to 2023-03-31

Newly reported

20

No longer reported

15

Increased

28

Reduced

18

Newly reported this quarter

Present now and absent from the immediately preceding comparable filing.

PositionKindSharesValue

LULU

LULULEMON ATHLETICA INC

LONG1,893,883$689.7 million

SHW

SHERWIN WILLIAMS CO

LONG2,252,060$506.2 million

EMERSON ELEC CO

EMERSON ELEC CO

LONG2,400,879$209.2 million

ZOOMINFO TECHNOLOGIES INC

ZOOMINFO TECHNOLOGIES INC

LONG6,666,576$164.7 million

CONSTELLATION ENERGY CORP

CONSTELLATION ENERGY CORP

LONG2,047,688$160.7 million

WORKDAY INC

WORKDAY INC

LONG642,447$132.7 million

COUPANG INC

COUPANG INC

LONG7,421,453$118.7 million

RIVIAN AUTOMOTIVE INC

RIVIAN AUTOMOTIVE INC

LONG5,250,417$81.3 million

SYNOPSYS INC

SYNOPSYS INC

LONG205,032$79.2 million

ALKERMES PLC

ALKERMES PLC

LONG2,781,917$78.4 million

TRAVELERS COMPANIES INC

TRAVELERS COMPANIES INC

LONG378,345$64.9 million

SNOW

SNOWFLAKE INC

LONG382,757$59.1 million

COLGATE PALMOLIVE CO

COLGATE PALMOLIVE CO

LONG660,698$49.7 million

DELL TECHNOLOGIES INC

DELL TECHNOLOGIES INC

LONG1,094,394$44.0 million

CNH INDL N V

CNH INDL N V

LONG2,827,515$43.2 million

MARSH & MCLENNAN COS INC

MARSH & MCLENNAN COS INC

LONG257,443$42.9 million

OPTION CARE HEALTH INC

OPTION CARE HEALTH INC

LONG1,090,497$34.6 million

VIKING THERAPEUTICS INC

VIKING THERAPEUTICS INC

LONG1,955,063$32.6 million

TJX COS INC NEW

TJX COS INC NEW

LONG414,401$32.5 million

FIRST REP BK SAN FRANCISCO C

FIRST REP BK SAN FRANCISCO C

LONG276,260$3.9 million

No longer reported this quarter

Present in the prior comparable filing and absent from this one.

PositionKindPrior sharesPrior value

ADVANCED MICRO DEVICES INC

ADVANCED MICRO DEVICES INC · COM

LONG1,905,600$123.4 million

ALBEMARLE CORP

ALBEMARLE CORP · COM

LONG337,339$73.2 million

AMERICAN INTL GROUP INC

AMERICAN INTL GROUP INC · COM NEW

LONG2,590,026$163.8 million

BROOKFIELD CORP

BROOKFIELD CORP · CL A LTD VT SH

LONG7,262,078$228.5 million

CAPRI HOLDINGS LIMITED

CAPRI HOLDINGS LIMITED · SHS

LONG810,479$46.5 million

CLOROX CO DEL

CLOROX CO DEL · COM

LONG768,839$107.9 million

CROWDSTRIKE HLDGS INC

CROWDSTRIKE HLDGS INC · CL A

LONG699,948$73.7 million

DOLLAR GEN CORP NEW

DOLLAR GEN CORP NEW · COM

LONG310,848$76.5 million

INSULET CORP

INSULET CORP · COM

LONG268,052$78.9 million

KE HLDGS INC

KE HLDGS INC · SPONSORED ADS

LONG8,084,334$112.9 million

LI AUTO INC

LI AUTO INC · SPONSORED ADS

LONG9,090,065$185.4 million

REGAL REXNORD CORPORATION

REGAL REXNORD CORPORATION · COM

LONG362,403$43.5 million

RH

RH · COM

LONG748,344$200.0 million

SHOCKWAVE MED INC

SHOCKWAVE MED INC · COM

LONG164,607$33.8 million

UBER TECHNOLOGIES INC

UBER TECHNOLOGIES INC · COM

LONG7,939,999$196.4 million

“No longer reported” means the position is absent from this comparable 13F filing. It does not prove the manager sold it: reporting thresholds, confidential treatment, corporate actions, or instrument changes can also explain the omission.

PositionKindSharesValueLong weightQuarter changeAI at filing · 1YAI now

V

Visa Inc.

LONG6,560,069$1.48 billion7.0%INCREASED—

1Y —

5Y —

MCKESSON CORP

MCKESSON CORP · COM · 58155Q103

LONG3,207,080$1.14 billion5.4%INCREASED—

1Y —

5Y —

UNH

UnitedHealth Group Inc.

LONG2,099,991$992.4 million4.7%INCREASED—

1Y —

5Y —

ELEVANCE HEALTH INC FORMERLY

ELEVANCE HEALTH INC FORMERLY · COM · 036752103

LONG2,154,556$990.7 million4.7%INCREASED—

1Y —

5Y —

GE AEROSPACE

GE AEROSPACE · COM NEW · 369604301

LONG8,612,232$823.3 million3.9%INCREASED—

1Y —

5Y —

FORTINET INC

FORTINET INC · COM · 34959E109

LONG11,875,384$789.2 million3.7%INCREASED—

1Y —

5Y —

AMZN

Amazon.com Inc.

LONG7,628,220$787.9 million3.7%REDUCED—

1Y +21.3%

5Y +126.1% · 32 models

APG

APi Group Corporation

LONG34,090,285$766.3 million3.6%INCREASED—

1Y +17.3%

5Y +93.0% · 30 models

LULU

Lululemon Athletica Inc.

LONG1,893,883$689.7 million3.2%NEWLY REPORTED—

1Y +13.4%

5Y +75.0% · 31 models

META

Meta Platforms Inc.

LONG3,229,914$684.5 million3.2%INCREASED—

1Y +21.0%

5Y +124.1% · 32 models

CHUBB LIMITED

CHUBB LIMITED · COM · H1467J104

LONG3,466,740$673.2 million3.2%REDUCED—

1Y —

5Y —

CSX

CSX Corporation

LONG22,057,119$660.4 million3.1%INCREASED—

1Y —

5Y —

ROIV

Roivant Sciences Ltd

LONG88,238,700$651.2 million3.1%UNCHANGED—

1Y +28.9%

5Y +148.1% · 32 models

HDFC BANK LTD

HDFC BANK LTD · SPONSORED ADS · 40415F101

LONG8,285,627$552.4 million2.6%REDUCED—

1Y —

5Y —

INTU

Intuit Inc.

LONG1,221,094$544.4 million2.6%INCREASED—

1Y +15.0%

5Y +90.9% · 31 models

SHW

Sherwin-Williams

LONG2,252,060$506.2 million2.4%NEWLY REPORTED—

1Y —

5Y —

TMO

Thermo Fisher Scientific Inc.

LONG856,836$493.9 million2.3%INCREASED—

1Y +12.3%

5Y +70.8% · 31 models

BRIDGEBIO PHARMA INC

BRIDGEBIO PHARMA INC · COM · 10806X102

LONG26,620,991$441.4 million2.1%UNCHANGED—

1Y —

5Y —

FTV

Fortive

LONG6,346,528$432.6 million2.0%INCREASED—

1Y —

5Y —

ROYALTY PHARMA PLC

ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104

LONG11,204,249$403.7 million1.9%INCREASED—

1Y —

5Y —

SEAGATE TECHNOLOGY HLDNGS PL

SEAGATE TECHNOLOGY HLDNGS PL · ORD SHS · G7997R103

LONG5,513,957$364.6 million1.7%REDUCED—

1Y —

5Y —

MSFT

Microsoft Corporation

LONG1,047,352$302.0 million1.4%REDUCED—

1Y +16.3%

5Y +98.3% · 32 models

MASTERCARD INCORPORATED

MASTERCARD INCORPORATED · CL A · 57636Q104

LONG796,740$289.5 million1.4%REDUCED—

1Y —

5Y —

AMERIPRISE FINL INC

AMERIPRISE FINL INC · COM · 03076C106

LONG941,040$288.4 million1.4%REDUCED—

1Y —

5Y —

KARUNA THERAPEUTICS INC

KARUNA THERAPEUTICS INC · COM · 48576A100

LONG1,501,074$272.7 million1.3%INCREASED—

1Y —

5Y —

ADAPTIVE BIOTECHNOLOGIES COR

ADAPTIVE BIOTECHNOLOGIES COR · COM · 00650F109

LONG29,993,708$264.8 million1.2%UNCHANGED—

1Y —

5Y —

VALVOLINE INC

VALVOLINE INC · COM · 92047W101

LONG7,398,713$258.5 million1.2%INCREASED—

1Y —

5Y —

ROGERS COMMS B

ROGERS COMMS B · COM · 775109200

LONG5,554,500$257.4 million1.2%INCREASED—

1Y —

5Y —

CADENCE DESIGN SYSTEM INC

CADENCE DESIGN SYSTEM INC · COM · 127387108

LONG1,225,306$257.4 million1.2%INCREASED—

1Y —

5Y —

ACADIA HEALTHCARE COMPANY IN

ACADIA HEALTHCARE COMPANY IN · COM · 00404A109

LONG3,354,110$242.3 million1.1%INCREASED—

1Y —

5Y —

BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC · COM · 09061G101

LONG2,168,617$210.9 million1.0%REDUCED—

1Y —

5Y —

EMERSON ELEC CO

EMERSON ELEC CO · COM · 291011104

LONG2,400,879$209.2 million1.0%NEWLY REPORTED—

1Y —

5Y —

GINKGO BIOWORKS HOLDINGS INC

GINKGO BIOWORKS HOLDINGS INC · CL A SHS · 37611X100

LONG143,085,126$190.3 million0.9%INCREASED—

1Y —

5Y —

MU

Micron Technology Inc.

LONG2,856,599$172.4 million0.8%REDUCED—

1Y +30.4%

5Y +145.3% · 31 models

UNUM GROUP

UNUM GROUP · COM · 91529Y106

LONG4,253,413$168.3 million0.8%INCREASED—

1Y —

5Y —

ZOOMINFO TECHNOLOGIES INC

ZOOMINFO TECHNOLOGIES INC · COMMON STOCK · 98980F104

LONG6,666,576$164.7 million0.8%NEWLY REPORTED—

1Y —

5Y —

XYZ

Block Inc. (formerly Square SQ)

LONG2,354,123$161.6 million0.8%REDUCED—

1Y +22.9%

5Y +125.3% · 31 models

CONSTELLATION ENERGY CORP

CONSTELLATION ENERGY CORP · COM · 21037T109

LONG2,047,688$160.7 million0.8%NEWLY REPORTED—

1Y —

5Y —

MOLINA HEALTHCARE INC

MOLINA HEALTHCARE INC · COM · 60855R100

LONG594,553$159.0 million0.7%INCREASED—

1Y —

5Y —

PGR

Progressive Corporation

LONG1,003,562$143.6 million0.7%INCREASED—

1Y —

5Y —

WORKDAY INC

WORKDAY INC · CL A · 98138H101

LONG642,447$132.7 million0.6%NEWLY REPORTED—

1Y —

5Y —

INHIBRX INC

INHIBRX INC · COM · 45720L107

LONG6,639,199$125.3 million0.6%UNCHANGED—

1Y —

5Y —

COUPANG INC

COUPANG INC · CL A · 22266T109

LONG7,421,453$118.7 million0.6%NEWLY REPORTED—

1Y —

5Y —

EQUITABLE HLDGS INC

EQUITABLE HLDGS INC · COM · 29452E101

LONG3,989,446$101.3 million0.5%REDUCED—

1Y —

5Y —

KBR INC

KBR INC · COM · 48242W106

LONG1,679,474$92.5 million0.4%INCREASED—

1Y —

5Y —

AMYLYX PHARMACEUTICALS INC

AMYLYX PHARMACEUTICALS INC · COM · 03237H101

LONG2,962,555$86.9 million0.4%REDUCED—

1Y —

5Y —

RIVIAN AUTOMOTIVE INC

RIVIAN AUTOMOTIVE INC · COM CL A · 76954A103

LONG5,250,417$81.3 million0.4%NEWLY REPORTED—

1Y —

5Y —

INSPIRE MED SYS INC

INSPIRE MED SYS INC · COM · 457730109

LONG346,576$81.1 million0.4%REDUCED—

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · NOTE 11/1 · 40131MAB5

LONG120,000,000$81.0 million—UNCHANGED—

1Y —

5Y —

CHARLES RIV LABS INTL INC

CHARLES RIV LABS INTL INC · COM · 159864107

LONG394,089$79.5 million0.4%REDUCED—

1Y —

5Y —

SYNOPSYS INC

SYNOPSYS INC · COM · 871607107

LONG205,032$79.2 million0.4%NEWLY REPORTED—

1Y —

5Y —

CATALENT INC

CATALENT INC · COM · 148806102

LONG1,201,210$78.9 million0.4%REDUCED—

1Y —

5Y —

ALKERMES PLC

ALKERMES PLC · SHS · G01767105

LONG2,781,917$78.4 million0.4%NEWLY REPORTED—

1Y —

5Y —

ZAI LAB LTD

ZAI LAB LTD · ADR · 98887Q104

LONG2,331,245$77.5 million0.4%INCREASED—

1Y —

5Y —

INTERNATIONAL FLAVORS&FRAGRA

INTERNATIONAL FLAVORS&FRAGRA · COM · 459506101

LONG812,680$74.7 million0.4%INCREASED—

1Y —

5Y —

4D MOLECULAR THERAPEUTICS IN

4D MOLECULAR THERAPEUTICS IN · COM · 35104E100

LONG3,937,914$67.7 million0.3%UNCHANGED—

1Y —

5Y —

TRAVELERS COMPANIES INC

TRAVELERS COMPANIES INC · COM · 89417E109

LONG378,345$64.9 million0.3%NEWLY REPORTED—

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · COM · 40131M109

LONG2,538,889$59.5 million0.3%REDUCED—

1Y —

5Y —

SNOW

Snowflake Inc.

LONG382,757$59.1 million0.3%NEWLY REPORTED—

1Y +19.4%

5Y +114.5% · 31 models

INTELLIA THERAPEUTICS INC

INTELLIA THERAPEUTICS INC · COM · 45826J105

LONG1,569,545$58.5 million0.3%REDUCED—

1Y —

5Y —

BSX

Boston Scientific

LONG1,136,881$56.9 million0.3%REDUCED—

1Y —

5Y —

NEWAMSTERDAM PHARMA COMPANY

NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES · N62509109

LONG3,915,870$52.6 million0.2%INCREASED—

1Y —

5Y —

COLGATE PALMOLIVE CO

COLGATE PALMOLIVE CO · COM · 194162103

LONG660,698$49.7 million0.2%NEWLY REPORTED—

1Y —

5Y —

DELL TECHNOLOGIES INC

DELL TECHNOLOGIES INC · CL C · 24703L202

LONG1,094,394$44.0 million0.2%NEWLY REPORTED—

1Y —

5Y —

CNH INDL N V

CNH INDL N V · SHS · N20944109

LONG2,827,515$43.2 million0.2%NEWLY REPORTED—

1Y —

5Y —

MARSH & MCLENNAN COS INC

MARSH & MCLENNAN COS INC · COM · 571748102

LONG257,443$42.9 million0.2%NEWLY REPORTED—

1Y —

5Y —

FARFETCH LTD

FARFETCH LTD · ORD SH CL A · 30744W107

LONG7,103,457$34.9 million0.2%INCREASED—

1Y —

5Y —

OPTION CARE HEALTH INC

OPTION CARE HEALTH INC · COM NEW · 68404L201

LONG1,090,497$34.6 million0.2%NEWLY REPORTED—

1Y —

5Y —

EDGEWISE THERAPEUTICS INC

EDGEWISE THERAPEUTICS INC · COM · 28036F105

LONG4,909,146$32.7 million0.2%INCREASED—

1Y —

5Y —

VIKING THERAPEUTICS INC

VIKING THERAPEUTICS INC · COM · 92686J106

LONG1,955,063$32.6 million0.2%NEWLY REPORTED—

1Y —

5Y —

TJX COS INC NEW

TJX COS INC NEW · COM · 872540109

LONG414,401$32.5 million0.2%NEWLY REPORTED—

1Y —

5Y —

PHARVARIS N V

PHARVARIS N V · COM · N69605108

LONG3,231,923$25.3 million0.1%UNCHANGED—

1Y —

5Y —

RALLYBIO CORP

RALLYBIO CORP · COM · 75120L100

LONG4,194,777$24.0 million0.1%UNCHANGED—

1Y —

5Y —

DAY ONE BIOPHARMACEUTICALS I

DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109

LONG1,558,563$20.8 million0.1%UNCHANGED—

1Y —

5Y —

PEPGEN INC

PEPGEN INC · COM · 713317105

LONG1,544,631$18.9 million0.1%UNCHANGED—

1Y —

5Y —

KINNATE BIOPHARMA INC

KINNATE BIOPHARMA INC · COM · 49705R105

LONG1,820,462$11.4 million0.1%UNCHANGED—

1Y —

5Y —

TREVI THERAPEUTICS INC

TREVI THERAPEUTICS INC · COM · 89532M101

LONG4,400,000$8.1 million0.0%UNCHANGED—

1Y —

5Y —

LIANBIO

LIANBIO · SPONSORED ADS · 53000N108

LONG3,564,173$7.0 million0.0%UNCHANGED—

1Y —

5Y —

TALARIS THERAPEUTICS INC

TALARIS THERAPEUTICS INC · COM · 87410C104

LONG3,289,617$6.2 million0.0%UNCHANGED—

1Y —

5Y —

FIRST REP BK SAN FRANCISCO C

FIRST REP BK SAN FRANCISCO C · COM · 33616C100

LONG276,260$3.9 million0.0%NEWLY REPORTED—

1Y —

5Y —

VERASTEM INC

VERASTEM INC · COM · 92337C104

LONG9,224,000$3.8 million0.0%UNCHANGED—

1Y —

5Y —

AI outlook values are averages across the latest successful run per covered model at the labeled cutoff. “No longer reported” does not necessarily mean sold; thresholds, confidential treatment, corporate actions, or instrument changes may explain an omission. Reviewed API mapping covers 45.2%of disclosed long-book value; exact editorial CUSIP mappings may add current-only AI coverage on this public page. Research use only. No warranty and not investment advice.